Dianthus Therapeutics, Inc. (DNTH) vs PTC Therapeutics, Inc. (PTCT)
Dianthus Therapeutics, Inc. and PTC Therapeutics, Inc. are both Biotechnology companies. Dianthus Therapeutics, Inc. and PTC Therapeutics, Inc. are of similar size ($5.2B and $5.1B). PTC Therapeutics, Inc. grew revenue faster over the last twelve months: −42.8% against −60.8%. PTC Therapeutics, Inc. has the higher net margin (−3.80% vs −10,097.0%) and the higher return on invested capital (15.2% vs −47.7%). Across the 16 metrics below, PTC Therapeutics, Inc. leads on 13 and Dianthus Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | DNTH | PTCT | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 92.99% | 65.16% |
| Operating margin | (11,441.39%) | 12.45% | 0.00% |
| Net margin | (10,096.95%) | (3.80%) | 0.00% |
| Free cash flow margin | (8,177.99%) | (29.76%) | 0.00% |
| Return on equity | (26.07%) | 20.64% | (57.72%) |
| Return on assets | (24.98%) | (1.30%) | (49.22%) |
| Return on invested capital | (47.74%) | 15.16% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack